Join
Live feed
·
PRReleasevia Quantisnow
Elanco Animal Health Incorporated logo

Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market

ByQuantisnow·Wall Street's wire, on your screen.
ELAN· Elanco Animal Health Incorporated
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELAN (Elanco Animal Health Incorporated) and more on Quantisnow.